等待开盘 09-17 09:30:00 美东时间
0.000
0.00%
Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the appointment of Thomas J. Schall, Ph.D., to Chairman of the Board of Directors.Dr.
09-16 19:12
THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The div...
08-02 04:01
At an Interim Analysis, Bemarituzumab Plus Chemotherapy Significantly Improved Overall Survival in People With FGFR2b Overexpression Compared to Chemotherapy Alone THOUSAND OAKS, Calif., Jun...
06-30 21:00
United Co RUSAL ( ($HK:0486) ) has issued an update. United Company RUSAL has b...
06-05 22:40
Breakthrough Second-Line Treatment Demonstrated Survival Advantage over Standard-of-Care Chemotherapy Late-Breaking Data Presented at ASCO 2025 and Simultaneously Published in The New Engla...
06-02 20:04
THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the fi...
05-02 04:01
Josh Gottheimer disclosed dozens of recent stock transactions including selling Nvidia stock and buying Tesla stock.
02-13 06:48
莫斯科 2025年2月10日 —— 作为全球领先的铝生产商之 一,俄铝获得了中国评级机构中诚信绿色金融科技(CCXGF)的ESG评级。该机构对俄铝给予“A-”评...
02-11 17:02
BeiGene Ltd ( ($HK:6160) ) just unveiled an announcement. BeiGene Ltd has annou...
01-20 18:40
Investment Establishes Second Facility in Holly Springs; Builds on Previous $550M Commitment THOUSAND OAKS, Calif., Dec. 5, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $1 bi...
2024-12-05 22:00